• About
  • Subscribe
  • Advertise
  • Contact
Thursday, January 22, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Feature

Optometrist uncovers life-threatening tumour

by rhiannon bowman
November 22, 2022
in Feature, Report
Reading Time: 8 mins read
A A
Specsavers optometrist Mr Surendran Naidoo (left) and patient Kelly Pabis who had a life-threatening tumour.

Specsavers optometrist Mr Surendran Naidoo (left) and patient Kelly Pabis who had a life-threatening tumour.

Share on FacebookShare on Twitter

An Illawarra optometrist who detected a pituitary tumour, leading to an urgent diagnosis and surgery that saved the patient’s life, highlights the importance of listening to the patient, especially when they dismiss general health complaints as ‘unrelated’.

Mr Surendran (Suren) Naidoo from Specsavers Dapto was recently awarded Specsavers’ Dame Mary Perkins Award after a visual field test found a patient had a bitemporal hemianopia, a classic sign of pituitary tumour.

The award, introduced in 2021, is reserved for an optometrist within the network that has shown an exceptional act of patient care in the past 12 months – something Naidoo exhibited in spades when Mrs Kelly Pabis came to see him with a vision complaint.

Pabis, a mother with two children – one with special needs – and a partner, had been to Specsavers Dapto a few months prior but there was nothing obvious or unusual about her presentation.

“Her primary complaint at the time was mild double vision but I was not the optometrist that saw Kelly when she initially presented,” Naidoo says.

“I picked up the consultation three months later when she returned, saying that she felt something wasn’t quite right with her vision and that her eyes weren’t working together. She didn’t mention it to me, but she told a staff member at reception that she missed a car in her visual field while driving. At the time she came to see me, she wasn’t experiencing any double vision.”

Mr Surendran (Suren) Naidoo from Specsavers Dapto found a patient had a bitemporal hemianopia, a classic sign of pituitary tumour.

After initial testing failed to provide a plausible explanation, Naidoo conducted a visual field test.

“I picked up what was very obviously a bitemporal hemianopia, but it was quite severe, it had crossed the midline and spread over to the other half. And there were quite a few errors on the visual field test,” he says.

“I said to her, ‘There are quite a few errors. I want to repeat the visual field test as soon as possible’. And she said, ‘Maybe I can come back in a couple of weeks’, but I told her this could potentially be more urgent than that.”

Pabis returned the following morning. This time, the visual fields reliability was better. A bitemporal hemianopia was more clearly defined and demarcated. Now, Naidoo faced a dilemma.

“You don’t want to scare the patient. I was very reluctant to tell her what I thought it was. But obviously I had to express the urgency of her situation, so I said to her ‘I’m hesitant to tell you what I suspect it is because it is not my area of expertise/speciality, but this has all the hallmarks and signs of a tumour of the pituitary gland’.”

He then questioned her further about other systemic symptoms and referred her to her GP with an urgent request for an MRI. To further complicate matters, the Specsavers Dapto store was about to close for three weeks for a planned expansion.

“During that time, we would have limited access to clinical records because we’d be working off site. I called Kelly and said, ‘We are closing for three weeks, and I’m particularly concerned about you. Have you seen your doctor yet? Because this is quite urgent’. She said ‘Well, actually,’ – she was very groggy when she spoke to me – ‘I’ve just come out of surgery’,” Naidoo recalls.

This was because – the day after seeing Naidoo – Pabis had an MRI and CT scan, returned home, and then received a call from Wollongong Hospital asking her to pack a bag and come immediately.

CT scan confirms tumour

Kelly Pabis’ CT scan showing the eyes (circled in blue) and the pituitary tumour (circled in red). The human eye is, on average, approximately 24mm, and the pituitary gland roughly 10mm. The tumour was 50-70mm. The optic nerves can be seen extending posteriorly from the middle of each eye (more visible on the right), with the medial and lateral recti muscles on each side. The optic nerves would meet at the optic chiasm which would be overlying the area where the tumour is shown in the scan, hence the effect on Pabis’ visual field. The part of the scan circled green is a sagittal section which shows the vertical extent of the tumour, and the red line denotes the level at which the main scan was done.

Listen in

Naidoo has diagnosed serious conditions before, but not in Australia.

“I’ve lived and practised in a few countries. In England, we had a girl with an optic nerve tumour, which in that particular case was potentially life threatening. I have detected a couple of pituitary tumours in my time, but nothing in Australia until now,” he says.

Naidoo says Pabis’ CT scans (pictured above) revealed the tumour was about 2-2.5 times the size of an eye.

“It was, by my estimate, about five to seven centimetres in diameter, and it was very obvious on the scan that it had started bleeding into the sinuses, and that was why she started getting vision-related symptoms.”

Pabis had been experiencing other symptoms for years but never thought to mention them during an eye test, because she didn’t think it was related to her eyesight, Naidoo says.

“She never mentioned the cortisone injections she was getting for joint pain,” he explains.

“According to Kelly, she had been seeing her GP since 2018, complaining of joint pains. The GP eventually diagnosed her with tendinitis. After doing multiple blood tests, they gave her cortisone injections every three months into her hands, elbows and feet just to keep the pain away because she had trouble walking and using her hands.”

It highlights the importance of taking a patient’s history, but also the delicacy in asking certain questions that might draw out pertinent information.

“I ask patients if they have any health issues, and if they say no, I’ll usually ask them if they have any other symptoms they can think of that they don’t think maybe related to their eyes. Because I find that very often patients are experiencing systemic symptoms, but they don’t think about it when you ask them,” Naidoo says.

“For example, I ask if they are taking any other medication, if they have any other symptoms they haven’t mentioned. And they’ll say, ‘I don’t think my eyes have anything to do with that’. Some patients can get quite offended and aggressive, wondering why I’m asking these questions, thinking it’s got nothing to do with their eyes.”

Mr Surendran (Suren) Naidoo discusses CT scan results with his patient, Mrs Kelly Pabis.

Naidoo says that after surgery, Pabis said she felt numb, meaning the absence of aches and pains that had plagued her.

“All those pains in her joints and extremities vanished. It was only at the three-month check-up when everything was stable that the neurologist said to Kelly, ‘When you walked in, I had no idea how you were still alive’. Her tumour was that severe. Subsequently, Kelly came back to see me a few months later and we repeated her tests. Her vision, in terms of her prescription, hasn’t changed very much but the bitemporal hemianopia has completely disappeared and her visual field is completely restored,” Naidoo says.

“That I found amazing because I’ve seen patients where it doesn’t come back.”

His astute observations in Pabis’ case is something that comes with experience.

“It’s a lesson to not just myself but other optometrists and even student optometrists that the case history never stops. After the patient comes in, it continues through the entire consultation and sometimes even subsequent consultations,” Naidoo says.

“I remember a lecturer of mine all those years ago telling us at university that when the patient walks into a room, nine out of 10 times they will indirectly tell you what’s wrong with them. You just need to listen.”

The patient

Pabis can easily recall the sequence of events that turned a regular visit to the optometrist into an urgent surgical procedure, and the reassuring manner of the man who helped her navigate her way through.

“When Suren told me there’s something pressing on my optic nerve, he wasn’t an alarmist. He was just very straightforward, very calming, very assuring. He said, ‘You need to see your GP to get a referral for an MRI. And then they’ll take it from there’.”

Mrs Kelly Pabis at Specsavers Dapto.

She got a GP appointment the following morning and was booked for an MRI in nearby Corrimal that afternoon. Midway through her MRI, Pabis was advised she also required a CT scan.

“At that point, I knew they’d found something because that wasn’t ordered.”

Pabis was given a copy of the scans and followed up with her GP the next day.

“I read the scans. I saw what was there, but I didn’t know what it meant.”

Her GP confirmed Naidoo’s suspicions and contacted a neurosurgeon. She soon received the call from Wollongong Hospital, advising her to pack a bag.

Once admitted to hospital, Pabis was given hydrocortisone injections to reduce her blood pressure and blood sugar levels, in preparation for surgery.

“I was admitted on Wednesday night. They did their own MRIs and scans on Thursday, and I had to meet with the Ear, Nose and Throat team because they take the tumour out through the back of your nose. They removed a big chunk of my cartilage and took a chunk of fat from my thigh to make a plug in the back of my head,” she says.

Time lapse

“I’m a very energetic person but back in 2018, I had no energy. I’d sleep for 12 hours and wake up exhausted. I went to the GP and underwent a range of tests,” Pabis recalls.

Unbeknown to her, the tumour was already wreaking havoc.

“In 2020/2021 I started getting very severe tendinitis. I was exercising and doing low impact things like aqua aerobics that don’t put a lot of strain on your body. But I was always getting tennis elbow, and nothing would heal. Painkillers wouldn’t even take the pain away. So I was getting cortisone injections, which would help for three months, but then the pain would return.”

Now, nearly 12-months post-surgery, Pabis is pain free and her vision is stable.

“I’m lucky that I had Suren to explain what was happening. I’m assuming a lot of people wouldn’t take that extra step and explain this is what these symptoms mean,” she says.

More reading

Specsavers unveils 2022 Doug Perkins Medal & Dame Mary Perkins Award winners

Inside the clinical speciality of ocular oncology

Recognising and categorising uveal melanoma

Related Posts

Image: irishmaster/stock.adobe.com.

New era in dry eye management highlighted

by Dr Margaret Lam
January 14, 2026

Following the recently released TFOS DEWS III framework, Dr Margaret Lam, head of optometry and professional services for 1001 Optometry...

n/a

2025 – the ophthalmic year in review

by rhiannon bowman
December 17, 2025

Therapeutic breakthroughs, workforce reckoning, and the rise of integrated sensory health – 2025 reshaped Australia’s eyecare landscape and shed new...

Practitioners must ensure their records are accurate, up to date, and not misleading. Image: Graini/stock.adobe.com.

Don’t fly blind on medical records

by Ruanne Brell
December 16, 2025

Patients may have understandable reasons to want medical records altered, but the rules for practitioners are pretty clear, and are...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited